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after injection or may remain permanent in some animals. Permanent titers were not seen in our study. The CF titers of horses tested intrapalpebrally on a second occasion may not disappear as rapidly as suggested by this study. The observation of decreasing CF titers during repeated testing for a few weeks while refraining from additional mallein priming is an indication of the final response an animal may make. Other serologic methods, such as the ELISA and western blotting of proteins, are being investigated for potential replacement of the mallein test as a supplemental test for glanders. kg, i.v.) -a spasmolytic and analgesic-in an antidiarrheic preparation, a containing styptics, neomycin sulfate (60 mg/ kg), and sulfadimidine (166 mg/kg) and phtalylsulfathiazole (166 mg/kg)-an absorbable and a nonabsorbable sulfonamide, respectively-given by nasogastric tube and in combination with sodium penicillin (33,000 IU/kg, i.v.) and procaine penicillin (12,500 IU/kg, i.m.).
On day 1 after admission, depression and abdominal pain had resolved. One episode of watery diarrhea was observed. Treatment was continued with novaminsulfone (20 mg/kg, i.v.), the antidiarrheic preparation (neomycin 30 mg/kg, sulfadimidine 83 mg/kg, phtalylsulfathiazole 83 mg/kg, p.o.), sodium pencillin (33,00 IU/kg, i.v.), and procaine penicillin (12,500 IU/kg, i.m.).
On day 2, the horse showed no clinical sign of illness, and the manure was normal. The horse received the antidiarrheic preparation (neomycin 30 mg/kg, sulfadimidine 83 mg/kg, phtalylsulfathiazole 83 mg/kg, p.o.) and procaine penicillin (12,500 IU/kg, i.m.).
On day 3, the colt developed peracute laminitis of both front hooves. Abdominal auscultation and manure consistency were normal. The horse was treated with phenylbutazone at an initial dose of 6.66 mg/kg, i.v., followed 10 hours later by a dose of 3.33 mg/kg, i.v., and procaine penicillin (12,500 IU/kg, i.m.).
On day 4, the horse received phenylbutazone (6.66 mg/ kg, i.v.), the antidiarrheic preparation (neomycin 30 mg/kg, sulfadimidine 83 mg/kg, phtalylsulfathiazole 83 mg/kg, p.o.), and procaine penicillin (12,500 IU/kg, i.m.).
On day 5, clinical signs of laminitis resolved. Diarrhea becoming gradually more watery was observed. Leucopenia (3.2 G/liter) and hypoproteinemia (46 g/liter) indicative of protein-losing enterocolitis were noticed for the first time. Intravenous fluid and plasma substitute therapy consisting of Ringer's lactate, sodium bicarbonate, and a gelatin preparation was initiated. The colt also received phenylbutazone (3.33 mg/kg, i.v.) and the antidiarrheic preparation (neomycin 60 mg/kg, sulfadimidine 166 mg/kg, phtalylsulfathiazole 166 mg/kg, p.o.).
On day 6, the horse's condition deteriorated. Laminitis symptoms reappeared. Diarrhea became watery and foul smelling. Abdominal pain and meteorism were observed. Leucopenia (1.4 g/liter) and hypoproteinemia (34 g/liter) were still present. Supportive therapy was continued as described before. The colt received phenylbutazone (1.66 mg/kg, i.v.) and the antidiarrheic preparation (neomycin 300 mg/kg, sulfadimidine 830 mg/kg, phtalylsulfathiazole 830 mg/kg, p.o.).
On day 7 after admission, profuse foul-smelling watery diarrhea was still observed. Abdominal pain had increased. The horse continued to receive supportive therapy and the antidiarrheic preparation (neomycin 300 mg/kg, sulfadimidine 830 mg/kg, phtalylsulfathiazole 830 mg/kg, p.o.) and was given 4 novaminsulfone doses (40 mg/kg each, i.v.). Uncontrollable colic, laminitis, and irreversible shock justified euthanasia on the same day.
During hospitalization, 5 fecal specimens were collected for bacteriologic examination. Tetrathionate broth enrichment with subsequent subculture on Salmonella-Shigella agar and brilliant green agar was performed for attempted isolation of Salmonella sp. Blood agar base containing 5% sheep's blood and Clostridium difficile b -selective agar were inoculated and incubated in an anaerobic atmosphere for attempted isolation of C. perfringens and C. dzjkile, respectively. A fecal filtrate was prepared for detection of C. dzficile cytotoxin in a cell culture assay using human lung embryonic fibroblasts and anti-C. difficile toxin A and toxin B antiserum. c, 1 Clostridium difficile and its cytotoxin were first detected in a fecal specimen collected on the fifth day after admission, which correlated with the onset of watery diarrhea. The samples collected subsequently on days 6 and 7 after admission were positive for C. difficile and its cytotoxin. Neither C. difficile nor its cytotoxin could be detected in the samples collected on the first and second day after admission. Clostridium difficile was only detected on selective medium; other intestinal bacteria made its detection on nonselective blood agar plates impossible. Flat, irregular, greyish colonies with a mat surface surrounded by a narrow zone of α-hemolysis and showing a chartreuse fluorescence under the ultraviolet lamp were presumptively identified as C. difficile. The iso-lates were definitely identified as C. difficile after detection of an isocaproic acid peak in gas-liquid chromatography and after biochemical testing. 1, 4 Salmonella enrichment procedure and culture for C. perfringens remained negative throughout the illness.
Pathologic and histopathologic examinations were performed. Intestinal content was fluid. Small intestine was macroscopically not modified. The walls of the caecum and of the ascending colon were edematous and showed multiple erosions. Histologically, there was a diffuse typhlocolitis with mononuclear cell infiltration and vasculitis with fibrinoid degeneration of the capillar wall. Lesions of the large intestine were severe enough to have accounted for the diarrhea.
The detection of C. difficile in intestinal content was correlated with the appearance of severe diarrhea and colic. Undetectable C. difficile and cytotoxin in the gut lumen on days 1 and 2 after admission might be explained by lack of sensitivity of assays or may indicate that C. difficile was a secondary problem. 4 The subsequent positive samples represent a significant finding that indicates colonization of gut with cytotoxin-producing C. difficile. The toxin-producing C. difficile strain isolated in this case, as in foals 5,7 humans, and laboratory animals, 2 may be responsible for the extensive intestinal wall damage and diarrhea observed in this horse.
The emergence of C. difficile on day 5 may be related to the therapy. In this case the horse received phenylbutazone, penicillin, and a combination of neomycin, sulfadimidine, and phtalylsufathiazole. Phenylbutazone-associated colitis is known to occur in equids. 11 Antibiotic-associated colitis, similar to C. difficile colitis of humans, has been observed. [9] [10] [11] Clostridium sp., which resembled C. cadaveris, coliforms, and Salmonella sp. were isolated in such cases. 9, 11 However, according to all reports, attempted isolation of C. difficile on selective media was not described. 3, [9] [10] [11] Onset of severe diarrhea and positive C. difficile culture and cytotoxin assay correlated with administration of phenylbutazone, penicillin, neomycin, and sulfonamides. Although these antimicrobial substances are not known to be important causes for antibiotic-associated colitis, 2,11 together with phenylbutazone, they may have been involved in the emergence of C. difficile in the intestines of this horse. This is the first report on isolation of C. difficile in association with diarrhea in an adult horse. Although isolation of C. difficile and the detection of cytotoxin in the feces of healthy adult horses has been reported, 3 our results (data not shown) and those of another study 6 indicate that C. difficile is not commonly found in feces of healthy adult horses.
Our findings indicate that C. difficile through toxin production and intestinal wall damage, 7 may have been the causative agent of severe diarrhea observed in this horse. Further investigation is necessary before a causal relationship between phenylbutazone, antibiotic treatment, and emergence of C. difficile in the gut lumen of adult horses can be established. This case emphasizes the need for attempted isolation of C. difficile in all diarrheic equine patients.
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